SCHEMBL5069895

SCHEMBL5069895

CCCC(C)(C)[CH]CC(C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10412582 0.81 CA1 (0.31)
SCHEMBL306061 0.81 MEN1 (0.31)
SCHEMBL5266333 0.77
SCHEMBL7303308 0.75
SCHEMBL5963338 0.70 TSHR (0.34)
SCHEMBL4619172 0.69
SCHEMBL4456323 0.68
SCHEMBL1933630 0.65
SCHEMBL17721454 0.65 TSHR (0.30)
SCHEMBL633249 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230091115-A1 CROSSLINKABLE POLYSILOXANE COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2023-03-23 US disclosed
EP-1934388-B1 METHOD OF DRUG DESIGN ALCHEMIA LTD (AU) 2012-12-05 EP disclosed
EP-1934388-A1 METHOD OF DRUG DESIGN Alchemia Ltd (AU) 2008-06-25 EP disclosed
WO-2007038829-A1 METHOD OF DRUG DESIGN ALCHEMIA LTD (AU) 2007-04-12 WO disclosed